Publications

Detailed Information

Pediatric Moyamoya Disease: An Analysis of 410 Consecutive Cases

DC Field Value Language
dc.contributor.authorKim, Seung-Ki-
dc.contributor.authorCho, Byung-Kyu-
dc.contributor.authorPhi, Ji Hoon-
dc.contributor.authorLee, Ji Yeoun-
dc.contributor.authorKim, Ki Joong-
dc.contributor.authorKim, In-One-
dc.contributor.authorLee, Joongyub-
dc.contributor.authorWang, Kyu-Chang-
dc.contributor.authorLee, Dong Soo-
dc.contributor.authorHwang, Yong-Seung-
dc.contributor.authorChae, Jong Hee-
dc.date.accessioned2012-05-25T07:30:57Z-
dc.date.available2012-05-25T07:30:57Z-
dc.date.issued2010-07-
dc.identifier.citationANNALS OF NEUROLOGY; Vol.68 1; 92-101ko_KR
dc.identifier.issn0364-5134-
dc.identifier.urihttps://hdl.handle.net/10371/76486-
dc.description.abstractObjective: Moyamoya disease (MMD) is a cerebrovascular occlusive disease of the bilateral internal carotid arteries that causes a compensatory abnormal vascular network at the base of brain. The rare incidence and various surgical techniques applied have limited the clinical research on MMD. Methods: We conducted a retrospective analysis of the surgical outcome of 410 pediatric MMD patients. All patients were treated in a relatively uniform scheme at a single institution. The surgical procedures consisted of bilateral encephaloduroarteriosynangiosis augmented by bifrontal encephalogaleo-/periosteal synangiosis. Logistic regression analyses were applied to reveal the prognostic factors for surgical outcome. Results: The overall clinical outcome was excellent in 66%, good in 15%, fair in 15%, and poor in 4% of the patients. Therefore, 81% of the patients had a favorable clinical outcome (excellent and good). Multivariate analyses revealed that infarction on presentation was associated with unfavorable clinical outcome (odds ratio [OR], 2.85; 95% confidence interval [CI], 1.49-5.46; p < 0.01) and decreased vascular reserve only on single-photon emission computerized tomography (OR, 0.07; 95% CI, 0.01-0.52; p < 0.01), with favorable clinical outcome. Interpretation: Our results indicate that an early diagnosis and active intervention before establishment of irreversible hemodynamic change are essential to achieve a favorable clinical outcome in children with MMD. ANN NEUROL 2010;68:92-101ko_KR
dc.language.isoenko_KR
dc.publisherWILEY-BLACKWELLko_KR
dc.titlePediatric Moyamoya Disease: An Analysis of 410 Consecutive Casesko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor김승기-
dc.contributor.AlternativeAuthor조병규-
dc.contributor.AlternativeAuthor피지훈-
dc.contributor.AlternativeAuthor이지연-
dc.contributor.AlternativeAuthor채종희-
dc.contributor.AlternativeAuthor김기중-
dc.contributor.AlternativeAuthor황용승-
dc.contributor.AlternativeAuthor김인원-
dc.contributor.AlternativeAuthor이동수-
dc.contributor.AlternativeAuthor이중엽-
dc.contributor.AlternativeAuthor왕규창-
dc.identifier.doi10.1002/ana.21981-
dc.citation.journaltitleANNALS OF NEUROLOGY-
dc.description.citedreferenceKuroda S, 2008, LANCET NEUROL, V7, P1056-
dc.description.citedreferenceKuriyama S, 2008, STROKE, V39, P42, DOI 10.1161/STROKEAHA.107.490714-
dc.description.citedreferenceSainte-Rose C, 2006, J NEUROSURG, V105, P437-
dc.description.citedreferenceOzgur BM, 2006, J CLIN NEUROSCI, V13, P105, DOI 10.1016/j.jocn.2005.04.008-
dc.description.citedreferenceSeol HJ, 2005, J NEUROSURG, V103, P439-
dc.description.citedreferenceKuroda S, 2005, STROKE, V36, P2148, DOI 10.1161/01.STR.0000182256.32489.99-
dc.description.citedreferenceSo Y, 2005, STROKE, V36, P1485, DOI 10.1161/01.STR.0000170709.95185.b1-
dc.description.citedreferenceCHOI IJ, 2005, J KOREAN NEUROSURG S, V38, P413-
dc.description.citedreferenceKuroda S, 2004, CHILD NERV SYST, V20, P302, DOI 10.1007/s00381-004-0924-4-
dc.description.citedreferenceKim SK, 2004, NEUROSURGERY, V54, P840, DOI 10.1227/01.NEU.0000114140.41509.14-
dc.description.citedreferenceScott RM, 2004, J NEUROSURG, V100, P142-
dc.description.citedreferenceGoda M, 2004, J NEUROSURG, V100, P156-
dc.description.citedreferenceKIM SK, 2004, NEUROSURGERY, V54, P844-
dc.description.citedreferenceKim SK, 2003, PEDIATR NEUROSURG, V38, P68, DOI 10.1159/000068050-
dc.description.citedreferenceKim SK, 2002, NEUROSURGERY, V50, P88-
dc.description.citedreferenceNomura S, 2001, CHILD NERV SYST, V17, P270-
dc.description.citedreferenceKim SK, 2000, CHILD NERV SYST, V16, P421-
dc.description.citedreferenceGolby AJ, 1999, NEUROSURGERY, V45, P50-
dc.description.citedreferenceImaizumi T, 1998, PEDIATR NEUROL, V18, P321-
dc.description.citedreferenceIkezaki K, 1997, STROKE, V28, P2513-
dc.description.citedreferenceHirotsune N, 1997, CLIN NEUROL NEUROSUR, V99, pS178-
dc.description.citedreferenceKansha M, 1997, CLIN NEUROL NEUROSUR, V99, pS110-
dc.description.citedreferenceRobertson RL, 1997, AM J NEURORADIOL, V18, P837-
dc.description.citedreferenceTouho H, 1996, STROKE, V27, P282-
dc.description.citedreferenceKURODA S, 1995, CHILD NERV SYST, V11, P214-
dc.description.citedreferenceUEKI K, 1994, MAYO CLIN PROC, V69, P749-
dc.description.citedreferenceMATSUSHIMA T, 1992, NEUROSURGERY, V31, P401-
dc.description.citedreferenceKARASAWA J, 1992, J NEUROSURG, V77, P84-
dc.description.citedreferenceMOUNTZ JM, 1988, J COMPUT ASSIST TOMO, V12, P247-
dc.description.citedreferenceFUKUYAMA Y, 1985, BRAIN DEV-JPN, V7, P21-
dc.description.citedreferenceKUROKAWA T, 1985, PEDIATR NEUROL, V1, P274-
dc.description.citedreferenceMATSUSHIMA Y, 1984, CHILD BRAIN, V11, P155-
dc.description.citedreferenceSUZUKI J, 1983, STROKE, V14, P104-
dc.description.citedreferenceKODAMA N, 1979, ARCH NEUROL-CHICAGO, V36, P16-
dc.description.tc10-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share